Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/15/2021
CDE Solicits Comments for the Proposed Technical Guidelines for Clinic...
11/15/2021
Milestone's Chinese Partner Files Chinese IND for Etripamil
11/15/2021
NMPA Issues the List of Reference Formulations for GQCE Studies (48th ...
11/15/2021
China to Release the Updated NRDL Soon
11/15/2021
NHC Solicits Comments on Draft Revision of the Provisions for National...
11/15/2021
Chinese Court Rules against Kangmei Pharma in 'Milestone' Case
11/15/2021
FDA Closes Warning Letter to Huahai over Valsartan, Opening Door for t...
11/15/2021
HebaBiz Biotech's P3 Trial in China for HBV Drug Clevudine (L-FMAU) ...
11/15/2021
SCMP: China May Approve First Covid-19 Drug Within Weeks
11/12/2021
CDE Issues the Technical Guidelines for Minimal Residual Disease Detec...
11/12/2021
NMPA Solicits Comments on the Draft Provisions for Quality Control of ...
11/12/2021
AZ Reports Mixed Q3/2021 Results, As It Begins to Manage Future Expect...
11/11/2021
NMPA Hosts Meeting on Drug, Medical Device, Cosmetic Regulation in Chi...
11/11/2021
Everest Med and Gilead Announce P2b Study of Sacituzumab Govitecan in ...
11/11/2021
Organon Reports Q3/2021 Earnings, Highlighting China Performance
11/11/2021
Blueprint Medicines and Zai Lab Announce License Deal for BLU-945 and ...
11/11/2021
Karuna Therapeutics and Zai Lab Announce Strategic Partnership for Ka...
11/11/2021
Beijing Intellectual Property Court Accepts China's First Drug Patent ...
11/11/2021
China Clears Trials on Using mRNA Vaccine as Booster Shot
11/11/2021
SK Biopharm Establishes Biotech Company in China
11/11/2021
AffaMed Launches Digital Medicines Unit
11/11/2021
PharmExec: China 2021 National Reimbursement Drug List Outlook (Update...
11/11/2021
How Hong Kong Plays a Central Role in The Biotech Investment Boom
11/10/2021
South China Province Plans $94 Million HPV Vaccination Pilot Program
11/10/2021
NDRC and MIIT Jointly Issue the Implementation Plan for Promoting High...
11/10/2021
Eli Lilly's Chinese NDA for RET Inhibitor Selpercatinib Accepted
11/10/2021
CDR Solicits Comments for the Proposed Guidelines for Preparing Drug P...
11/10/2021
CPhI Survey: US Pharma Growth to Exceed Both India and China in 2022
11/10/2021
Merck KGaA Veteran Launches I/O Startup Marengo Therapeutics with $80M
11/9/2021
Biosynth Carbosynth and Shengquan Acquire Kexing Biopharma's API Plant
Page:
106
/
719
Total number of articles:
21546
:
[First]
[<<]
[104]
[105]
[106]
[107]
[108]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit